The authors showed that FUBP1 and its methylation are essential for prostate cancer progression, and a competitive peptide interfering with FUBP1 methylation suppressed the development of prostate cancer.
[Journal of Clinical Investigation]
PRMT5 Mediated FUBP1 Methylation Accelerates Prostate Cancer Progression
